Clinical, serologic, and immunogenetic features of familial idiopathic inflammatory myopathy

Arthritis and Rheumatism
L G RiderF W Miller

Abstract

To describe the clinical, serologic, and immunogenetic features of familial idiopathic inflammatory myopathy (IIM) and to compare these with the features of sporadic IIM. Clinical signs and symptoms, autoantibodies, HLA-DRB1 and DQA1 alleles, and GM/KM phenotypes were compared among 36 affected and 28 unaffected members of 16 unrelated families in which 2 or more blood relatives developed an IIM. In addition, findings in patients with familial IIM were compared with those in 181 patients with sporadic IIM. The families included 3 pairs of monozygotic twins with juvenile dermatomyositis, 11 families with other siblings or relatives with polymyositis or dermatomyositis, and 2 families with inclusion body myositis. The clinical features of familial IIM were similar to those of sporadic IIM, although the frequency of myositis-specific autoantibodies was lower in familial than in sporadic IIM. DRB1*0301 was a common genetic risk factor for familial and sporadic IIM, but contributed less to the genetic risk of familial IIM (etiologic fraction 0.35 versus 0.51 in sporadic IIM). Homozygosity at the HLA-DQA1 locus was found to be a genetic risk factor unique to familial IIM (57% versus 24% of controls; odds ratio 4.2, corrected P = 0.00...Continue Reading

References

Jul 1, 1976·Medicine·F C Arnett, L E Shulman
Sep 1, 1992·Acta Neurologica Scandinavica·D NagarajaB S Rao
Nov 15, 1992·Annals of Internal Medicine·C M WeyandJ J Goronzy
Jun 1, 1992·The Journal of Clinical Investigation·C M WeyandJ J Goronzy
Jul 1, 1992·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·D A Carson
May 1, 1991·Archives of Neurology·R MassaS Carpenter
Mar 1, 1991·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·R Grubb
Jun 1, 1991·Arthritis and Rheumatism·I García-de la TorreL Hernández-Vazquez
Feb 1, 1991·European Journal of Immunogenetics : Official Journal of the British Society for Histocompatibility and Immunogenetics·H ErlichP S Walsh
Apr 1, 1990·British Journal of Rheumatology·P A Sanders, D M Grennan
Jul 19, 1990·The New England Journal of Medicine·R C HennekamW Kuis
Sep 1, 1990·Arthritis and Rheumatism·I N TargoffF W Miller
Aug 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·R K SaikiH A Erlich
Jan 1, 1989·Neuroepidemiology·P MantaD Vassilopoulos
May 1, 1986·Neurology·Y HaratiE W Bergman
Oct 1, 1973·Journal of Neurology, Neurosurgery, and Psychiatry·R M Lewkonia, P H Buxton
Jan 1, 1995·Annual Review of Medicine·G T Nepom
Oct 1, 1994·Clinical and Experimental Immunology·M J GarleppF L Mastaglia
Sep 1, 1994·Annals of the Rheumatic Diseases·M D de JuanE Cuadrado
Dec 1, 1994·British Journal of Rheumatology·C O StephensK I Welsh
Nov 1, 1993·Current Opinion in Rheumatology·L A Love, F W Miller
May 1, 1993·The Clinical Investigator·S BeyenburgF Jerusalem
Feb 1, 1996·Journal of Neurology·M NaumannK V Toyka
Dec 1, 1996·Journal of Medical Genetics·D JawaheerW E Ollier
Nov 1, 1996·Current Opinion in Rheumatology·S R Ytterberg
Apr 1, 1997·Annals of Neurology·Z ArgovS Mitrani-Rosenbaum
Dec 1, 1963·Annals of Internal Medicine·J A LAMBIE, I F DUFF
Feb 1, 1996·Genome Génome / Conseil National De Recherches Canada·E S Krafsur, J J Obrycki
Feb 1, 1996·Genome Génome / Conseil National De Recherches Canada·M Pillay

❮ Previous
Next ❯

Citations

Mar 23, 2011·Zeitschrift für Rheumatologie·I Melchers
Dec 21, 2000·Current Rheumatology Reports·A M Reed
Aug 21, 2009·Current Rheumatology Reports·Terrance P O'Hanlon, Frederick W Miller
Dec 12, 2001·Neurochemistry International·Soo Youl KimPeter M Steinert
Sep 16, 2000·Current Opinion in Rheumatology·G M Cawkwell
Nov 25, 2000·Current Opinion in Rheumatology·E A ShamimF W Miller
Aug 14, 2008·Current Opinion in Rheumatology·Elizabeth A Shaw, Anne M Stevens
Feb 2, 2011·Journal of Veterinary Internal Medicine·A C HaleyG D Shelton
Jun 11, 2011·Arthritis Research & Therapy·Hector ChinoyRobert G Cooper
Mar 20, 2012·Best Practice & Research. Clinical Rheumatology·Melinda Vincze, Katalin Danko
Nov 1, 2009·Reumatología clinica·Carlos Riebeling-Navarro, Arnulfo Nava
Apr 20, 2001·Seminars in Cutaneous Medicine and Surgery·I Caro
Jul 19, 2003·Scandinavian Journal of Immunology·K MüntzingA Oldfors
Jan 1, 2003·Rheumatic Diseases Clinics of North America·Ann M Reed, Steven R Ytterberg
Nov 3, 2011·Scandinavian Journal of Rheumatology·P MathiesenS Nielsen
Oct 28, 2016·The Journal of Dermatology·Chang-E ZhangSen Yang
Sep 24, 2002·Arquivos de neuro-psiquiatria·Margô Gomes de Oliveira KarnikowskiOtávio Tolêdo Nóbrega
Sep 25, 2002·Journal of Child Neurology·Chang-Yong TsaoJohn T Kissel
Apr 21, 2018·Nature Reviews. Rheumatology·Frederick W MillerKanneboyina Nagaraju
Aug 28, 2018·Current Opinion in Rheumatology·Iago Pinal-Fernandez, Andrew L Mammen
Nov 30, 2006·Arthritis and Rheumatism·Gulnara MamyrovaUNKNOWN Childhood Myositis Heterogeneity Collaborative Study Group
Dec 21, 2000·Current Rheumatology Reports·E A Shamim, F W Miller
Jun 29, 2011·Journal of Bone and Mineral Metabolism·Hiroko MoriYoshiya Tanaka
Oct 22, 2003·Current Opinion in Rheumatology·Gulbu Uzel, Lauren M Pachman
Dec 11, 1999·Current Opinion in Neurology·A Oldfors, C Lindberg
Apr 20, 2019·Frontiers in Immunology·Ann Marie ReedJeffrey Arthur Dvergsten
Apr 9, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Zivana TezakLauren M Pachman
Jun 17, 2021·Annals of the Rheumatic Diseases·Weng Ian CheMarie Holmqvist

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.